1. Fentanyl and Alfentanil Plasma Protein Binding in Preterm and Term Neonates
- Author
-
Annette Wilson, Richard L. Stiller, Gina Fedel, Francis X. McGowan, S. Chakravorti, Peter J. Davis, and Barbara A. Israel
- Subjects
Immunodiffusion ,medicine.medical_specialty ,Radioimmunoassay ,Gestational Age ,In Vitro Techniques ,Fentanyl ,Internal medicine ,Blood plasma ,medicine ,Humans ,Alfentanil ,Serum Albumin ,Radial immunodiffusion ,business.industry ,Infant, Newborn ,Albumin ,Gestational age ,Blood Proteins ,Orosomucoid ,Blood proteins ,Analgesics, Opioid ,Anesthesiology and Pain Medicine ,Endocrinology ,Anesthesia ,business ,Infant, Premature ,Protein Binding ,medicine.drug - Abstract
The effects of gestational age (GA) and plasma protein concentrations on the plasma protein binding of fentanyl and alfentanil were studied in preterm and term neonates. Binding experiments were performed using split-cell equilibrium dialysis. Fentanyl and alfentanil concentrations were measured using specific radioimmunoassay, and the proteins albumin and alpha-1-acid glycoprotein (AAG) were measured using radial immunodiffusion assays. In the preterm neonates, 77% of fentanyl and 65% of alfentanil was bound. In the term neonates, 70% of fentanyl and 79% of alfentanil was bound. The binding ratio of alfentanil showed a positive correlation with gestational age and AAG concentration. The binding ratio of fentanyl showed a weak, negative correlation with gestational age. These data indicate that fentanyl and alfentanil are not interchangeable at the GA studied because of age-related changes in protein binding.
- Published
- 1997
- Full Text
- View/download PDF